| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.35 | 0.06 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.25 | 2e-06 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.06 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.19 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-07 |